| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/15/2013 | CA2400842C Novel compounds |
| 01/15/2013 | CA2323011C Method for the development of an hiv vaccine |
| 01/15/2013 | CA2291853C Color-encoding and in-situ interrogation of matrix-coupled chemical compounds |
| 01/10/2013 | WO2013006853A1 Spectroscopic analysis of oil sands ore face for real time ore blend management |
| 01/10/2013 | WO2013006828A1 Method of analyzing cardiovascular disorders and uses thereof |
| 01/10/2013 | WO2013006810A1 Assays for detecting neutralizing autoantibodies to biologic therapy with tnf alpha |
| 01/10/2013 | WO2013006722A1 Hcv genotype 3 replicons |
| 01/10/2013 | WO2013006721A1 Hcv genotype 4 replicons |
| 01/10/2013 | WO2013006704A1 Systems and methods for clinical evaluation of psychiatric disorders |
| 01/10/2013 | WO2013006619A1 Rna-yy1 interactions |
| 01/10/2013 | WO2013006490A2 Antibodies that specifically bind to tim3 |
| 01/10/2013 | WO2013006474A2 Regulatory t cells and methods of identifying, obtaining and using to treat immuno-based disorders |
| 01/10/2013 | WO2013006405A1 Dynamic biochemical tissue analysis assays and compositions |
| 01/10/2013 | WO2013006364A1 Establishment of patient - or person - specific cardiac myocyte cell lines from human induced pluripotent stem cells (ipscs) |
| 01/10/2013 | WO2013006334A2 Variable gas source gas exchange system |
| 01/10/2013 | WO2013006218A1 Methodology for determination of nitrogen content in nitrocellulose |
| 01/10/2013 | WO2013006156A1 Method for increasing specificity of diagnostic tests for autoimmune diseases |
| 01/10/2013 | WO2013006148A1 Method utilizing enzyme substrates producing insoluble fluorescent products and chromogens, and use in combination with enzyme substrates producing soluble products |
| 01/10/2013 | WO2013006129A1 Treatment of prostate cancer and a method for determining the prognosis for prostate cancer patients |
| 01/10/2013 | WO2013006059A1 Myositis |
| 01/10/2013 | WO2013006024A1 Diagnosis of entamoeba histolytica |
| 01/10/2013 | WO2013005790A1 Method for evaluating bio-oxidation, device therefor, procedure therefor, program therefor, system therefor, data communication terminal device therefor, and method of searching for a substance to prevent or ameliorate bio-oxidation |
| 01/10/2013 | WO2013005649A1 Anti-human ccr6 antibody |
| 01/10/2013 | WO2013005269A1 Method for immobilizing albumin on self-assembled monolayer |
| 01/10/2013 | WO2013005083A1 A sorting system |
| 01/10/2013 | WO2013005012A1 Methods for predicting mammalian embryo viability |
| 01/10/2013 | WO2013005003A1 Assay |
| 01/10/2013 | WO2013004989A1 Coated nanoparticles |
| 01/10/2013 | WO2013004976A1 Method of determining the hydrostructural parameters of a soil |
| 01/10/2013 | WO2013004970A1 Improved method for detecting and/or quantifying an analyte at the surface of a cell |
| 01/10/2013 | WO2013004927A1 Device for measurement coupled with water parameters of soil |
| 01/10/2013 | WO2013004883A1 Method for determining arginine and the methylated derivatives thereof |
| 01/10/2013 | WO2013004848A1 Caveolin-1 in tumor-associated fibroblasts as biomarker for tumor progression |
| 01/10/2013 | WO2013004823A1 Test strip for a medical meter |
| 01/10/2013 | WO2013004717A1 Biochemical markers for neurodegenerative conditions |
| 01/10/2013 | WO2013004650A1 Sampling procedure for polymer-based solutions used in underground formations |
| 01/10/2013 | WO2013004647A1 Biomarker of renal impairment |
| 01/10/2013 | WO2013004593A1 Method and apparatus for estimation of heat value |
| 01/10/2013 | WO2013004373A1 Test instrument and method for calibrating a test instrument |
| 01/10/2013 | WO2013004239A1 Adaptive embryo selection criteria optimized through iterative customization and collaboration |
| 01/10/2013 | WO2013004152A1 Device for detecting oxidable substrance and method thereof |
| 01/10/2013 | WO2013003935A1 Centrifugal microfluidic platform |
| 01/10/2013 | WO2013003930A1 Initiators, method and kit for the differential diagnosis of crohn´s disease and ulcerative rectocolitis by means of immunohistochemical labelling of the proteins b-catenin and retinoblastoma |
| 01/10/2013 | WO2013003898A1 Method for detection of cancer in a patient |
| 01/10/2013 | WO2013003897A1 Endorepellin peptides and fragments thereof as biomarkers for physical activity |
| 01/10/2013 | WO2012156476A3 Methods for screening substances capable of modulating the replication of an influenza virus |
| 01/10/2013 | WO2012155123A3 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 01/10/2013 | WO2012154688A3 Methods and devices to control fluid volumes, reagent and particle concentration in arrays of microfluidic drops |
| 01/10/2013 | WO2012154672A3 Point-of-care, medical condition screening kit |
| 01/10/2013 | WO2012149145A3 Ocular detection of amyloid proteins |
| 01/10/2013 | WO2012148516A3 Bioaffinity sensors based on surface monolayers |
| 01/10/2013 | WO2012145516A3 Methods and kits for quantitative determination of total organic acid content in a coolant |
| 01/10/2013 | WO2012144783A3 Apparatus for measuring perviousness to water vapor |
| 01/10/2013 | WO2012144755A3 Composition and kit for the diagnosis of mild cognitive impairment, which measure an expression level of lipocalin-2, and method for providing information for the diagnosis of mild cognitive impairment |
| 01/10/2013 | WO2012142502A3 Advanced analyte sensor calibration and error detection |
| 01/10/2013 | WO2012142301A3 Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury |
| 01/10/2013 | WO2012142179A3 Magnetically induced microspinning for super-detection and super-characterization of biomarkers and live cells |
| 01/10/2013 | WO2012141554A3 Complex in which an anti-cotinine antibody is bound to a binder material of cotinine and a binding substance, and a use therefor |
| 01/10/2013 | WO2012135824A3 Method of screening for colon cancer using biomarkers |
| 01/10/2013 | WO2012134093A3 Integrated collecting and dispensing device |
| 01/10/2013 | WO2012122374A3 Non-invasive methods for diagnosing chronic organ transplant rejection |
| 01/10/2013 | WO2012120288A3 Method, array and use for determining the presence of pancreatic cancer. |
| 01/10/2013 | WO2012118539A3 Automated particulate concentration system |
| 01/10/2013 | WO2012109353A9 Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans |
| 01/10/2013 | WO2012107451A3 Method to screen compounds influencing plant cell growth and production |
| 01/10/2013 | WO2012083258A3 Electrochemical sensors |
| 01/10/2013 | WO2012054870A3 Biomarkers for hcv infected patients |
| 01/10/2013 | WO2012006475A1 Compounds and methods for inhibiting phosphate transport |
| 01/10/2013 | US20130013259 Anti-terrorism water quality monitoring system |
| 01/10/2013 | US20130012797 Method for managing treatment of a particular health condition via a mobile phone device |
| 01/10/2013 | US20130012603 Methods for assessing the risk of cardiovascular disease |
| 01/10/2013 | US20130012568 Kits for Detecting Direct Oxidation of Calcium/Calmodulin Dependent Protein Kinase II and Associated Diagnostic and Therapeutic Methods |
| 01/10/2013 | US20130012553 Methods for stabilizing joint damage in subjects using xanthine oxidoreductase inhibitors |
| 01/10/2013 | US20130012550 Methods for prognosis and monitoring cancer therapy |
| 01/10/2013 | US20130012536 Modulators of atp-binding cassette transporters |
| 01/10/2013 | US20130012519 Biomarker Identifying the Reactivation of STAT3 After Src Inhibition |
| 01/10/2013 | US20130012441 Prediction and prevention of preeclampsia |
| 01/10/2013 | US20130012411 Testing a patient population having a cardiovascular condition for drug efficacy |
| 01/10/2013 | US20130012409 Diagnostic and Prognostic Markers for Cancer |
| 01/10/2013 | US20130011934 Biopolymer sequencing by hybridization of probes to form ternary complexes and variable range alignment |
| 01/10/2013 | US20130011933 Method of diagnosing bladder cancer |
| 01/10/2013 | US20130011929 Peripheral opioid receptor antagonists and uses thereof |
| 01/10/2013 | US20130011913 Immunoassays, methods for carrying out immunoassays, immunoassay kits and method for manufacturing immunoassay kits |
| 01/10/2013 | US20130011902 Stimulation of the synthesis of the activity of an isoform of lysyl oxidase-like loxl for stimulating the formation of elastic fibers |
| 01/10/2013 | US20130011869 Novel monoclonal antibodies and method of immunological analysis of d-dimer |
| 01/10/2013 | US20130011868 Novel platelet activation marker and method for determination thereof |
| 01/10/2013 | US20130011866 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
| 01/10/2013 | US20130011865 Marker for detecting gastric cancer and method for detecting gastric cancer |
| 01/10/2013 | US20130011863 Follistatin-Like Protein-1 as a Biomarker for Sepsis |
| 01/10/2013 | US20130011862 Rapid process for detection of microorganisms with magnetic particles |
| 01/10/2013 | US20130011861 Modulators of p-selectin glycoprotein ligand 1 |
| 01/10/2013 | US20130011860 Methods for detecting insulin autoantibody |
| 01/10/2013 | US20130011858 Methods for predicting pregnancy outcome in a subject by hcg assay |
| 01/10/2013 | US20130011857 Complement factor h for oxidative stress disease conditions |
| 01/10/2013 | US20130011856 Cartridge for automatic measurement and measuring device using the same |
| 01/10/2013 | US20130011855 Methods for Determining Aged Based Accumulation of Senescent Cells Using Senescense Specific DNA Damage Markers |
| 01/10/2013 | US20130011853 Anti-hedgehog antibodies |
| 01/10/2013 | US20130011852 Compounds that interact with kinases |
| 01/10/2013 | US20130011851 Lateral Flow Immunoassay With Encapsulated Detection Modality |
| 01/10/2013 | US20130011850 Steroidogenesis modified cells and methods for screening for endocrine disrupting chemicals |